EX-CELL^® CD昆虫细胞培养基

See how the Sf9 rhabdovirus-free cell line was developed and how we’ve developed a companion chemically-defined insect cell media for protein and viral expression.

To address scalability challenges of AAV manufacturing, we developed an HEK293 suspension cell line that can be used across many serotypes. Get the data in this article.

The current status and future manufacturing of AAV-based gene therapies is discussed in this podcast transcript, including how to streamline large-scale manufacturing.

Minimize the complexities of cell and gene therapy production. Switch to upstream viral vector platforms to enhance scalability and simplify GMP manufacturing.

针对病毒载体生产的转染解决方案采用悬浮细胞系、化学成分明确的培养基以及性能已得到证明的工艺。

A transfection-based solution to viral vector production using a suspension cell line, chemically defined medium, and a process with proven performance at scale.